C ells maintain a dynamic balance of key intracellular parameters that is constantly perturbed by internal and external 'stressors' . The 'stress response' is the process elicited by stressors to restore homeostasis. A critical aspect of all molecular and physiological stress response systems is their requirement for energy, in part provided by mitochondria 1 . Mitochondria are unique organelles with their own genome, which sustain life through energy transformation and perform several biochemical functions implicated in intracellular signalling and dynamics. Mitochondrial stress responses are central to cell fate, health and disease at the tissue and organismal level ( Fig. 1) 2,3
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. Mitochondria are unique organelles with their own genome, which sustain life through energy transformation and perform several biochemical functions implicated in intracellular signalling and dynamics. Mitochondrial stress responses are central to cell fate, health and disease at the tissue and organismal level ( Fig. 1 ) 2, 3 . Mitochondrial dynamics are also critical to stress responses 2 . Understanding the types of mitochondrial stressors, their interplay with mitochondrial dynamics and the mechanisms that orchestrate how cells or organisms respond to them is critical to understanding the transition between health and disease. In the following sections we discuss the mechanisms underlying these facets of mitochondrial biology and their integration with other contributing factors in adaptation and maladaptation of cells, tissues and organisms.
Mitochondrial stressors and cellular stress responses
Stressors can be chemical or physical in nature, and acute or chronic in periodicity (Fig. 1, left) . Many stressors target non-mitochondrial cell constituents but pathways often converge on the mitochondrion, reflecting its key role in energy production and signalling required for surviving and adapting to stressors 1 . Mitochondria are integral to programmed cell death, which is required for removal of cells fatally damaged by stressors that exceed the cell's adaptive capacity 2, 3 . Other stressors directly target and interfere with mitochondrial functions, including oxidative phosphorylation, intermediate metabolism, cell death, calcium signalling or cell dynamics 2 . Among stressors that directly target mitochondria, are genetic alterations in mitochondrial and nuclear DNA genes (mtDNA and nDNA genes, respectively) that encode> 1,000 mitochondrial proteins, including the mtDNA maintenance machinery 3 . Accumulation of mtDNA mutations, or mtDNA depletion, interferes with oxidative metabolism and disrupts electron transport chain (ETC) function, which impairs mitochondrial ATP production, one-and two-carbon metabolism, and the transmembrane potential (Δ Ψ m) and proton motive force that drive multiple mitochondrial functions 3 . nDNA mutations may directly alter other mitochondrial functions, including their dynamics 4 .
Deprivation of mitochondrial fuel substrates or oversupply of nutrients, including glucose and fatty acids, are also mitochondrial stressors 4 . Disturbances of intracellular iron 5 and calcium (Ca 2+ ) homeostasis, such as prolonged stimulation by Ca 2+ -linked agonists, insufficient cytoplasmic Ca 2+ clearance or decreased mitochondrial Ca 2+ gatekeeping, are also stressors 6, 7 . Various stressors induce increased reactive oxygen species (ROS) production by the respiratory chain, with mitochondria being a prominent source of ROS and subject to ROS-mediated injury 8 . Physiological ETC activity generates ROS that may support signalling mechanisms. However, ETC dysfunction leads to increased ROS production that is often pathogenic 3, 8 . Although mitochondrial ROS is an ETC stress response, mitochondria can also be the target of ROS produced by other organelles or of extracellular origin (for example, generated by ultraviolet (UV) light); in which case ROS is a mitochondrial stressor that can elicit changes in mtDNA (for example, mutations or deletions), mitochondrial lipids and proteins 8 . Numerous cell permeable toxins also target mitochondria. Rotenone and antimycin A inhibit complex I and III, respectively, to enhance ROS, whereas the proton ionophores FCCP and DNP depolarize mitochondria to uncouple ETC from ATP production 9 . Alcohol is metabolized in the mitochondria to give rise to toxic products 10 . Staurosporine targets apoptosis-related proteins located at, or translocated to, mitochondria, including BAX and BAK (ref.
11
). Pro-apoptotic chemicals are commonly used research reagents, whereas inhibitors of anti-apoptotic BCL-2 family proteins have been developed for anti-tumour therapy 11 . Infectious agents such as bacteria and viruses also commonly target mitochondrial function and structure, and elicit immune responses involving mitochondria.
Mitochondrial dynamics
Mitochondrial function and response to stimuli are defined by their complex structure and dynamics. Mitochondria contain outer and inner mitochondrial membranes (OMM and IMM, respectively), which border the intermembrane space (IMS) and the matrix. The IMM associates with the OMM at contact points and undergoes extensive inward folding to form cristae. Each of these compartments has discrete functions in oxidative metabolism, biosynthetic pathways and signalling 12 . Mitochondrial dynamics involve reshaping, rebuilding and recycling events that support mitochondrial stability, abundance, distribution and quality, and allow compensatory changes when cells are challenged (Fig. 2a,b) .
Mitochondrial dynamics in adaptive and maladaptive cellular stress responses reshaping mechanisms and responses to stressors
Mitochondrial reshaping mechanisms include mitochondrial motility, mitochondrial fusion/fission and other homotypic interactions (such as nanotunneling and intermitochondrial junctions), as well as heterotypic mitochondrial interactions (such as the coupling of mitochondria with endoplasmic reticulum).
Mitochondrial motility. Mitochondrial trafficking and localization throughout the cytoplasm depends on interactions with the cytoskeleton and molecular motors 16 . MIRO1/2 are OMMlocalized small GTPase-like proteins 17 that anchor mitochondria to kinesin or dynein (Fig. 2a) (motors for anterograde or retrograde displacement along microtubules, respectively) using TRAK1/2 adaptors 16 . Myosin motors can also facilitate mitochondrial positioning 18 and short-distance movement along actin filaments 19 . Stable mitochondrial localization in axons is supported by syntaphilin, an OMM protein directly linking mitochondria to microtubules 20 . Asymmetry and compartmentalization of cellular behaviour require mitochondrial transport to different cellular regions. Motility is central to partitioning mitochondria for cell division 21, 22 . Mitochondrial transport along axons and dendrites, and accumulation in regions of high-energy demand, are required to maintain neural activity 23, 24 . Movement of energy-producing organelles may redistribute the spatial pattern of ATP production and Ca 2+ buffering 25 . Mitochondrial movements also support fusion/fission 26 and organelle recycling 27 . Impairment of axonal mitochondrial transport is linked to neurological phenotypes in mouse models targeting MIRO (refs 23, 28, 29 ) or MFN2 (refs 30, 31 ) ( Table 1) -uptake, forms the basis for a homeostatic mechanism in mitochondrial distribution and calcium signalling 25, 33 . ROS also suppress mitochondrial motility in Ca 2+ -dependent and independent manners 34, 35 . Furthermore, extracellular glucose elevation leads to mitochondrial motility inhibition by activating O-GlcNAc transferase to target TRAK proteins (ref. 36 ). Whereas Ca 2+ signalling transients, ROS and glucose fluctuations are physiological regulators of mitochondrial motility, larger and more prolonged changes in the same factors can pathologically alter movement dynamics (Fig. 2c ) 7, 8 . Ca 2+ and ROS mutually strengthen each other and can generate cycles impairing motility 35, 37 . In skeletal myoblasts, H 2 O 2 inhibits mitochondrial motility and prompts fragmentation 38 . In neurons and other cell types, ROS induces Fission of mitochondria is also supported by association with the ER, and triggered by DRP1 and dynamin2 (Dyn2) GTPases. Recently described dynamic processes are: mitochondrial nanotunnel formation that also depends on interaction with microtubules; intra-mitochondrial dynamics directed by MICOS (mitochondrial contact site and cristae organizing system), OPA1 and F 1 /F 0 (ATP synthase); and matrix volume changes, depending on IMM K + channels and the PTP. b, Rebuilding and recycling processes. Mitochondrial biogenesis involves expression of organelle-targeted proteins on activation of transcriptional factors PGC1α and YY1, and phospholipid biosynthesis. Recycling of mitochondria can be mediated by MDVs regulated by Vps35, syntaxin-17 and mitophagy, driven by PINK1 and Parkin. Mitochondria host cell-death signalling pathways control cytochrome c release to decide cell survival or removal c, Mitochondrial reshaping under stress. Diverse stressors (red) trigger adaptive responses in mitochondrial reshaping processes. Stressors commonly cause mitochondrial motility arrest, hyperelongation and donut formation or total fragmentation. Under stress, ER-mitochondria contacts usually become tighter but loosening has also been documented. Review ARticle | FOCUS
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Ca 2+ transients and activates mitogen-activated protein kinases (MAPKs), such as JNK and p38, to cause mitochondrial motility inhibition 35, 37 . Starvation also activates p38 MAPK phosphorylation of ubiquitin ligase Gp78, interfering with mitochondrial motility and disrupting ER-mitochondrial contacts 39 . In injured axon zones, mitochondrial density increases to support axon regeneration by local energy production 40 , highlighting an adaptive response to acute injury. Mitochondrial density might increase because mitochondria 
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NaTuRe Cell BIology are retained by stabilized syntaphilin 41 . Yet, in cortical neurons after mild, reversible mitochondrial stress induced by antimycin A, mitochondria carrying syntaphilin are recycled by retrograde trafficking and fusion with late endosomes and lysosomes 42 . In cancer cells, hypoxia and ROS target alternatively spliced syntaphilin, enhancing mitochondrial trafficking associated with tumour cell migration and invasion 43 . Mitochondrial transport in axons is suppressed by deletion or expression of disease mutants of the fusion protein mitofusin 2 (MFN2) that interacts with MIRO (ref. 30 ). Following stress, degradative pathways also target the mitochondrial motility machinery. Dissipation of Δ Ψ m leads to PINK1 stabilization, inducing Parkin to mark MIRO for proteasome degradation and halting mitochondrial movement, possibly to prevent spreading of dysfunctional organelles along neurons 44 . In cortical neurons, mitochondrial damage triggers PINK1-Parkin to induce MIRO1 ubiquitination on Lys27, arresting mitochondria for degradation 45 . Oxidative stress activates the OMM-associated PGAM5-KEAP1-Nrf2 pathway leading to MIRO2 proteasomal degradation, causing mitochondrial retrograde trafficking and perinuclear localisation 46 . Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain that is required for hypoxia-induced transcription 47 . Oxidative stress and starvation are also sensed by Myo19, an actin-linked motor that retains mitochondria in areas of low ATP/ADP ratio 48 .
Following mechanical injury to neurons, axon regeneration depends on ARMCX1 gene expression localized to mitochondria, which enhances mitochondrial transport 49 . Mitochondrial stress responses involve the mitochondrial motility machinery, allowing mitochondrial redistribution to areas where bioenergetic needs are increased, or by recycling damaged organelles 25 .
Mitochondrial fusion and fission dynamics.
Mitochondrial movements along cellular tracks facilitate encounters between two distant organelles, permitting fusion 26, 32 involving successive mixing of compartments: OMM merging, mediated by the mitofusin 1 (MFN1) and MFN2 GTPases; IMS mixing; IMM fusion, mediated by OPA1 GTPase; and matrix complementation 50, 51 . The fusion product can remain as an individual organelle or undergo division following cytoplasmic DRP1 GTPase recruitment to the OMM by MFF (ref. Mitochondrial fission can also be facilitated by motors of opposing directions 26 ( Fig. 2a) . Fusion-mediated mitochondrial-component-sharing supports multiple elements of mitochondrial biology: mtDNA integrity 56 , mitochondrial respiration 57 , Δ Ψ m equilibration 58 , apoptosis 51 and signalling events such as [Ca 2+ ] c oscillations 59 . Fission can facilitate motility and is required for segregation of damaged mitochondria for mitophagy 58 , mtDNA replication 60 and mitochondrial redistribution during cell division 61 . Thus, mitochondrial fusion/fission dynamics is central to organelle quality control and a variety of cellular functions. To test the physiological relevance of fusion/fission proteins, and the pathophysiology associated with their perturbation, genetic models have been created for MFNs, OPA1 and DRP1 in mouse (Table 1) . Whole-body knockouts for each protein interfere with early development and are embryonically lethal [62] [63] [64] [65] . Organ-specific knockouts are either lethal or cause severe dysfunction of the affected organ, as observed in the nervous system 23, [66] [67] [68] [69] , heart [70] [71] [72] [73] [74] and skeletal muscle [75] [76] [77] . Mice expressing human diseasecausing mutations of MFN2 or OPA1 display the symptoms of Charcot-Marie-Tooth type 2A disease (CMT2A) or autosomal dominant optical atrophy (ADOA), respectively 63, 67, [78] [79] [80] [81] [82] [83] (Table 1) . Mitochondrial fusion/fission balance is regulated transcriptionally and post-transcriptionally. MFN2 expression is enhanced by PGC1α (peroxisome proliferator gamma coactivator 1 alpha) 84 . MFN1/2 and OPA1 levels, as well as activity, are affected by phosphorylation 85 , redox modifications 86 , acetylation 87 and ubiquitination 88, 89 . OPA1 is proteolytically processed by the AAA proteases OMA1 and YME1L, which are regulated by Δ Ψ m (ref. 90 ) and OXPHOS activity 91 , respectively. OPA1 function is regulated by cardiolipin in the IMM to prompt fusion 92 . DRP1 recruitment to the OMM and fission are controlled by Ca 2+ -and cAMP-stimulated phosphoregulatory events 93 . Through a combination of the mechanisms described above, stressors can cause a hyper-elongated mitochondrial network by stimulation of fusion and/or inhibition of fission; or fragmented mitochondria by stimulation of fission and/or inhibition of fusion. Hyper-elongation and fragmentation can occur sequentially within minutes to hours 35 (Fig. 2c) . A given stressor can induce distinct mitochondrial fusion/fission phenotypes in different cells and tissues, and different stressors can induce opposing phenotypes in the same cell type. Although incompletely understood, specific mitochondrial responses to a given stressor are likely determined by a combination of interacting factors, including fusion/fission factor basal expression, biochemical and metabolic cell state, chronic stressors, and other unknown factors. Thus, a complex relationship exists between stressors and dynamic fusion/fission phenotypes.
In terms of mechanisms affecting fusion, several stressors converge on OMA1 and YMEL1 proteases, which control OPA1 fusogenic activity 94 . Increased OXPHOS activity in cells grown on ketogenic carbon sources promotes YME1L-mediated OPA1 processing, increasing fusion 91 . Mitochondrial poisons that cause oxidative stress and ATP depletion suppress YME1L activity through degradation 94 . Mouse embryonic fibroblasts (MEFs) and cell line exposure to UV-irradiation, serum deprivation or protein synthesis inhibitors, leads to mitochondrial hyperfusion dependent on MFN1, OPA1 and IMM scaffold protein SLP2 (ref. 95 ). SLP2 restricts OMA1-mediated OPA1 processing to support hyperfusion 96 . Downstream of hyperfusion, and following engagement of the mitochondrial E3 ubiquitin ligase/SUMOylase MULAN (also known as MAPL), NF-κ B is activated, likely as an adaptive mechanism to promote anti-apoptotic protein expression 97 . Pathological cardiac stress leads to mitochondrial fusion inhibition through OPA1 hyperacetylation, normally prevented by the mitochondrial matrix deacetylase, SIRT3 (ref. 87 ). Conversely, pressure overload challenge in the heart activates TNF-α receptor type 2, OPA1 expression and fusion dependent on STAT3 and NF-κ B activation 98 . As to fission mechanisms and regulation, starvation induces hyperfused mitochondria by inhibiting fission, thereby protecting the organelle from autophagic degradation 93, 99 . High glucose causes mitochondrial fission to mediate apoptosis in pancreatic betacells 100 . Similarly, high glucose exposure of cardiac cells leads to elevated ROS and mitochondrial fission 101 , whereas acute intracellular ROS elevation leads to DRP1-mediated mitochondrial fission 102 . ETC inhibition by rotenone or antimycin A recruits DRP1, promoting fission to support autophagic removal of damaged organelles by AMPK activation mediated by MFF phosphorylation 103 . AMPK likely senses an AMP/ATP ratio increase to trigger phosphorylation MFF but other factors may function in this process, as glucosestarvation-related increases in AMP/ATP ratio are associated with inhibited fission. The oxidative stress-response pathway Keap1-NRF2 is a key regulator of DRP1 levels, leading to hyperelongated mitochondria and cell survival 104 . Mitochondrial depolarization combined with sustained [Ca 2+ ] c elevation activates the cytoplasmic phosphatase calcineurin that dephosphorylates DRP1 Ser637 to stimulate mitochondrial fission 105 . In skeletal muscle, metabolic oversupply during sustained contractile inactivity also causes DRP1 Ser616 phosphorylation associated with mitochondrial fragmentation 106 . Conversely, on a high-fat diet, calcineurin inhibition prevents DRP1 Ser637 dephosphorylation leading to hyperelongated mitochondria and improved metabolic performance in skeletal . Mechanical stress induced by bacterial infection also leads to mitochondrial fission 108 . DRP1 activation has been linked to apoptosis mediated by BCL-2 family proteins 2 . However, most of the above results suggest that long mitochondria provide protection against stressors. Whereas shorter mitochondria are thought to be maladaptive, this is not always the case, as mitochondrial shortening by fission supports lymphocyte migration 109 and effector T cell activation 110 . Fusion/fission perturbation by stressors gives rise to complex mitochondrial shapes. Hypoxia-reoxygenation and other stressors can cause donut-shaped mitochondria through autofusion between the two ends of tubular mitochondria 111 . In H9c2 cells, this is preceded by matrix expansion dependent on permeability transition pore (PTP) or K + channel opening and the ensuing partial detachment from the microtubular track 111 . Donut formation is a stress response and may protect against swelling-induced structural damage 111 .
Nanotunnels. Even when physically separated by several microns, mitochondria can form connections through 60-200 nm wide double membrane tubules called mitochondrial nanotunnels 112 . Nanotunnels have been observed in cardiac 113 and skeletal muscle 59 , and can be generated in a cell-free system by kinesin (Kif5b) in a microtubule-and ATP-dependent manner 114 . Protein exchange along nanotunnels 115 suggests that mitochondrial nanotunnels may serve functional but possibly not genetic complementation between non-adjacent mitochondria, in tissues with restricted mitochondrial motility 112 . In mice carrying a ryanodine receptor (RyR) 2 mutation (A4860G), associated with human catecholaminergic polymorphic ventricular tachycardia due to aberrant Ca 2+ homeostasis, mitochondria display increased nanotunnel communication 116 . Mitochondrial nanotunnels are frequent in skeletal muscle of mitochondrial myopathy patients carrying mtDNA deletions or mutations, suggesting that nanotunnels support mitochondrial adaptation to genetic stressors 117 .
Homotypic mitochondrial contacts. Mitochondria can exhibit trans-mitochondrial coordination in muscle tissues. When joined by molecularly undefined electron-dense intermitochondrial junctions (IMJs), two adjacent mitochondria can exhibit aligned cristae 118 . IMJs are molecularly independent from MFNs but are induced within 30 minutes by physically tethering mitochondria through inter-organellar linkers in vitro 118 . Increased energetic demand during muscle contraction 119 , and decreased energetic demand during inactivity 106 , increase and decrease IMJ number, respectively. MitoNEET, an OMM iron-sulfur cluster-forming protein, functions in IMJs and has been linked to H 2 O 2 -induced mitochondrial fragmentation 120 .
Heterotypic inter-organelle communication.
Mitochondria dynamically form close contacts with various intracellular organelles (< 100 nm gap width), which represent a small fraction of the total organellar surface and allow effective local communication without altering the global milieu (Fig. 2a) 121, 122 . The most frequent mitochondrial companion is the endoplasmic reticulum (ER). ERmitochondrial membrane contacts are reorganized to meet local needs 123 and are supported by physical protein-based tethers 124 . Over 60 proteins have been implicated in tethering and many support specific functions 122 . MFN2 can cause diverse contact phenotypes in different paradigms, which may be determined by other tethering proteins 122 . These contacts function in phospholipid biosynthesis, Ca 2+ transfer between ER and mitochondria, ROS signalling, mitochondrial fission, autophagy and mtDNA synthesis 121, 122 . Thus, ER-mitochondrial contacts represent a dynamic aspect of mitochondrial behaviour impacted by stressors and relevant to other mitochondrial functions. . Serum starvation or ER-specific stressors such as tunicamycin cause ER-mitochondrial contact tightening to promote cell death 124, 125 . Stressors converging on ROS/redox dysregulation have also been linked to changes in ER-mitochondrial contact architecture-hypoxia widens contacts in a Nogo-dependent manner 126 , whereas cardiac ischemia/reperfusion causes tighter contacts through PTPIP51 (ref. 127 ). Virus infections, including cytomegalovirus 128 , chronic hepatitis C or acute RNA viruses 129 , enhance ER-mitochondrial contacts. Thus, a variety of stressors promote closer contacts that might facilitate local communication between interacting organelles (Fig. 2c) .
Stressors also alter the distribution of specific proteins relative to organelle contacts, influencing contact function. Palmitoylation affects calnexin distribution 130 and a shift to a hypoxic/reducing environment influences ERO1α to leave ER-mitochondrial contacts 131 . Stressors affect Ca 2+ and ROS signalling pathways at the ER-mitochondrial interface by several mechanisms. The IP 3 receptor (IP3R), which mediates local Ca 2+ transfer in the ER, and the RYR Ca 2+ channel in the sarcoplasmic reticulum, are targets of redox regulation 132, 133 . Moreover, alteration of ER-mitochondrial Ca 2+ communication affects other aspects of mitochondrial dynamics, including fragmentation 134 and autophagy 135 . Several signalling pathways of BCL-2 family proteins that reside and exert pro-survival or pro-death functions in the ER and OMM have been linked to the ER-mitochondrial contacts 136, 137 . Sphingolipid metabolism and ceramide production at ER-mitochondrial contacts is central to BAK/BAX-mediated OMM permeabilization and ensuing cell death 138 . In addition to the ER, mitochondria form dynamic contacts with other organelles, such as lysosomes, peroxisomes and lipid droplets, which may function during stress, for example by fatty acid shuttling from lipid droplets to mitochondria during starvation 139 .
Intra-mitochondrial dynamics to shape cristae and adjust matrix volume. A distinctive feature of mitochondrial ultrastructure is IMM folding into cristae 12 , which allows ETC component organization into supercomplexes to enhance bioenergetic efficiency 140 . Mitochondrial cristae display dynamic changes with different metabolic states 141 . Cristae shape is supported by F 1 F 0 ATPase localization at the IMM bending regions 142 . Cristae junctions are secured by the mitochondrial contact-site protein complex (MICOS), which helps shape cristae and organize the ETC complexes 143, 144 . MIC60, a MICOS component critical to IMM-bending to support cristae formation 145 , interacts with OPA1 (ref. 84 ). Oligomeric OPA1 is needed to keep cristae junctions closed 146 . As a physiological adaptation to increased metabolic demands, cristae remodelling with increased density occurs in exercised skeletal muscle 147 . During starvation, OPA1 oligomerization is enhanced to keep cristae narrow, which is required to promote F 1 F 0 ATPase assembly and maintain ATP-linked respiration. Mutant OPA1 (Q297V) that undergoes oligomerization, but is defective in fusion, can support survival during starvation 148 . Apoptosis-promoting stressors through the BH3-only protein BID, interfere with OPA1 oligomerization and trigger cristae junction opening to make cytochrome c available for release 146, 149 . ROS modulator 1 (ROMO1) regulates OPA1 to control cristae organization and enhance mitochondrial resistance to BID-induced cristae junction opening and cytochrome c release 150 .
Mitochondrial dynamic stress responses in disease
The previous section discussed specific mechanisms by which stressors influence different facets of mitochondrial dynamics, Review ARticle https://doi.org/10.1038/s41556-018-0133-0
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NaTuRe Cell BIology promoting cellular adaptation or demise. Here, we discuss three stereotypic mitochondrial stress response patterns and how they are translated into disease states. Abnormal mitochondrial dynamics are associated with morphological, genetic and biochemical mitochondrial recalibrations that trigger cellular stress responses 2, 3 . These recalibrations engender the production of diffusible signals that influence the organism at multiple levels ( Fig. 1, right) , and cause disease in some cases by inducing mtDNA instability 3 . Stress responses can have both adaptive and maladaptive effects. Adaptive effects contribute to resilience, whereas maladaptive effects contribute stress pathophysiology and disease state development. As adaptation becomes exhausted and maladaptation becomes dominant, the organism transitions from physiology to pathology (Fig. 3a) . Based on onset and duration, we distinguish 3 types of stressors which cause different stress response patterns: early onset, chronic; late onset, acute; and late onset, chronic (Fig. 3b-d) .
Early onset chronic stressors. Early onset stressors are generally chronic and produce progressive disease (Fig. 3b) . Inherited genetic defects in genes of the fusion/fission machineries are stressors that permanently alter mitochondrial dynamics or motility throughout life 3, 83 . The consequences can be devastating but the initial defect can often be compensated for by increased activity of the quality control provided by mitochondrial dynamics. When the defect impairs a fraction of normal dynamics, these defects can be compensated for, but may be aggravated beyond compensation by the accumulation of subsequent stressors 3 . The accumulation of stressors, such as secondary mtDNA mutations, may overwhelm the system and cause disease once the biochemical threshold is reached 151 . In humans, the threshold between physiological adaptation and pathology may vary based on particular mutations, but is estimated to be around 60% of the mtDNA mutation load 151 .
As in animal models (Table 1) , autosomal mutations-particularly in the fusion machinery (MFN2 (ref. 152 ), OPA1 (ref. 63 )) but also in fission factors (DRP1 (ref. 153 ), MFF (ref. 154 )) and a motor adaptor (TRAK1 (ref.
155 ))-lead to mitochondrial disorders. The shared clinical symptoms for these neurodegenerative diseases are neurological impairments such as retinal ganglion cell degeneration and neuromuscular symptoms. OPA1, named after its genetic mutation, was shown to be the main cause of ADOA (refs 156,157 ). MFN2 mutations cause approximately 20% of CMT2A cases, an inherited peripheral neuropathy characterized by abnormal mitochondrial trafficking 30, 31 . To date, no disease has been associated with mutations in MFN1. In part, the pathogenic mechanism uptake), illustrated here as the transition from green to purple; adaptation reflects the activation of secondary processes (for example, gene expression, mitochondrial biogenesis and increased contractility) that act to compensate for bioenergetic defects. Survival indicates the ability of cells and organs to sustain viability and normal functions. b, Early onset stressors are generally chronic in nature, such as inherited mtDNA and nDNA mutations that alter key components of mitochondrial dynamics and bioenergetics. Early onset chronic stressors may cause a substantial initial loss in bioenergetic capacity (that is, fitness) and lead to progressive decline in survival. c, Late onset acute stressors are punctual, arising from chemical exposure, ischemia or other reversible events. Late onset acute stressors generally induce a rapid and substantial loss of bioenergetic capacity and survival associated with an induction of compensatory adaptive processes that may remain elevated beyond the duration of the stressor, enabling the maintenance of sub-maximal but sufficient functional capacity. d, Late onset chronic stressors are those that also arise punctually later in life but remain active and often progress in intensity, such as metabolic dysregulation in diabetes, neurodegenerative processes and toxic compound exposure from substance abuse. Late onset chronic stressors generally lead to progressive decline in bioenergetics and survival, the progression of which is reduced by compensatory adaptive mechanisms. 75, 158, 159 ). However, in many cases, ETC dysfunction is absent, indicating that abnormal fusion activity and motility represent a sufficient stressor to affect cell-level and organlevel function 153, 154 . The canonical mitochondrial fusion/fission and motility dynamics proteins regulate other aspects of mitochondrial behaviours, and proteins such as MFN2 can cause disease through impairments of ER-mitochondrial communication, Ca 2+ signalling or mitophagy 160 .
Late onset acute stressors. Late onset stressors are generally acquired, can be relatively short-lived, and do not generally affect mitochondrial quality or the ability to produce functional organelles (Fig. 3c) . Excess of metabolic substrates, such as acute hyperglycemia and hyperlipidemia, can activate PKA to promote DRP1-dependent fission 4, 161 . Hyperglycemia also increases ROS to mediate fission, and fission further augments ROS emission 162 . Both MFN1 and MFN2 are involved in metabolic sensing and regulation of whole-body energy homeostasis 163, 164 , illustrating the adaptive cellular role of mitochondrial dynamics in response to acute metabolic stressors. Ischemia/reperfusion injury, such as myocardial infarction or stroke, usually occurs late in adult life. The acute drop in oxygen and metabolic substrates, followed by rapid reoxygenation, causes substantial remodelling of mitochondrial morphology dominated by DRP1-mediated fission 165, 166 , and the system rarely recovers full function. Some toxins cause acute and permanent tissue injury, such as doxorubicin that engages ROS and causes mtDNA damage in cardiomyocytes 167 .
Late onset chronic stressors. Late onset chronic stressors mostly occur in adult life but produce lasting deleterious effects on the system (Fig. 3d) . Poorly controlled diabetes, which manifests as the chronic elevation of blood glucose and lipids, represents a chronic stressor that generally develops later in life 168 . The metabolic oversupply of diabetes increases fission, with concurrent accumulation of mtDNA defects in various tissues 168 . Obesity is associated with reorganization of ER-mitochondrial contacts resulting in mitochondrial Ca 2+ overload, compromised mitochondrial oxidative capacity and augmented oxidative stress 169 . Repeated environmental and chemical stressors, such as smoking and chronic alcohol abuse, are also late onset chronic stressors that influence mitochondrial dynamics and potentially alter the trajectory of primary mitochondrial diseases 170 . Chronic alcohol exposure leads to mitochondrial fusion inhibition in cardiac myocytes 115 and in skeletal muscle by targeting MFN1 protein levels 59 . A number of stressors may therefore converge on different facets of mitochondrial dynamics and, when too high in duration and intensity, lead to maladaptive changes which, alone or in combination with other stressors, may culminate in disease.
Most neurodegenerative diseases have been linked to primary or secondary changes in mitochondrial dynamics 171, 172 . In addition to inherited genetic defects in the proteins assigned to mitochondrial dynamics (see early onset chronic), mutations in other proteins (including amyloid precursor protein, presenilins and α -synuclein) common to neurodegenerative diseases also cause interference with mitochondrial dynamics 169, 173 . The dynamic structure and function of the ER-mitochondrial contacts seems to be affected in many of these cases 173, 174 . However, altered ER-mitochondrial contacts and other impairments of mitochondrial dynamics (that is, fragmentation) are also documented in sporadic cases, supporting the view that mitochondrial dynamics are central to the pathogenesis of neurodegeneration 174, 175 . ROS and Ca 2+ dysregulation, often documented in neurodegenerative diseases, can interfere with various aspects of mitochondrial dynamics and can be part of cycles that drive disease progression 34 .
Conclusions and looking forward
Much progress has been made in dissecting the molecular mechanisms that underlie mitochondrial dynamics. Recent in vitro and in vivo work has begun to map the effects of specific disease-causing stressors on various facets of mitochondrial and cellular responses. A challenge ahead will be to understand how the resulting mitochondrial and cellular recalibrations, both acute and chronic, interact to produce symptoms. Single models with limited readouts do not appear sufficiently precise or inclusive to explain the complex phenotypic variability in symptoms that manifest in animals and individuals with abnormal mitochondrial dynamics. Given the interaction of stressors and stress responses at the molecular, cellular and organismal levels (Fig. 1, right) , future efforts may require technical advances that enable concurrent measurement of functions across multiple levels of organization, and the development of multivariate, biologically meaningful methods and concepts to integrate such multi-level data. This would contribute to understanding the processes that translate stressors into symptoms and disease.
Ultimately, the outcome of this work should be to develop rational targeted approaches to influence adaptive and maladaptive dynamic physiological responses (Fig. 3) and to restore them towards healthy states. This will require the ability to accurately map dynamic processes at the molecular and organellar levels, and to monitor changes in bioenergetics over considerable time periods. A further challenge will be to experimentally address these questions in physiologically relevant disease models. Most studies highlighting the pathophysiological relevance of mitochondrial motility have been performed in experimentally convenient systems, such as neural axons and dendrites in vitro, in which mitochondrial trafficking is prominent and easily tracked 16 , but may not represent in vivo behaviour 176 . Understanding the physiological role of mitochondrial reshaping, rebuilding and recycling in specialized tissues remains vastly unexplored and an inspiring challenge for the field.
